EMERYVILLE, Calif.,
Oct. 1, 2020 /PRNewswire/
-- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic
biotechnology company in Clean Health and Beauty markets through
its consumer brands, and a top supplier of sustainable and natural
ingredients, today announced that it is currently delivering
samples to pharmaceutical companies of a sustainable and scalable
alternative to shark-based vaccine adjuvants currently used in a
number of vaccines, including those directed at influenza and
COVID-19. Amyris expects commercialization and production of its
alternative squalene for adjuvants in the fourth quarter.
- Squalene is a natural oil made in the liver of sharks and used
as an ingredient within adjuvants in vaccines to improve efficacy
of a vaccine.
- Shark-based squalene is used in influenza vaccines and in
various COVID-19 vaccines.
- Amyris has developed a process to naturally produce
sugarcane-derived squalene as an effective alternative to
shark-derived squalene.
Adjuvants are added to vaccines to boost immune system response
and those including squalene are typically sourced from deep-sea
shark livers, a non-sustainable and non-scalable resource.
"Our patented technology and manufacturing processes have
already produced a number of applications to, among other things,
create a scalable treatment for malaria, and a variety of
sustainably-sourced clean products and ingredients that are better
for people and our planet," said John
Melo, President and CEO. "We believe our capabilities are
critical toward supporting a healthier planet while protecting its
resources, including the lives of sharks essential to the marine
ecosystem. We are committed to delivering the world's needs for a
high performance, low cost sustainable squalene without killing a
single shark. We believe this is essential in responding to
pandemics and delivering vaccines for all people in need on our
planet."
About Amyris
Amyris (Nasdaq: AMRS) is a science and
technology leader in the research, development and production of
sustainable ingredients for the Clean Health & Beauty and
Flavors & Fragrances markets. Amyris uses an impressive array
of exclusive technologies, including state-of-the-art machine
learning, robotics and artificial intelligence. Our ingredients are
included in over 3,000 products from the world's top brands,
reaching more than 200 million consumers. Amyris is proud to own
three consumer brands - all built around its No Compromise® promise
of clean ingredients: Biossance™ clean beauty skincare, Pipette™
clean baby skincare and Purecane™, a zero-calorie sweetener
naturally derived from sugarcane. For more information, please
visit www.amyris.com.
Forward-Looking Statements
This release contains
forward-looking statements, and any statements other than
statements of historical fact could be deemed to be forward-looking
statements. These forward-looking statements include, among other
things, statements regarding scalability, quantity and timing of
commercial production of squalene and relative efficacy of squalene
derived from different sources. These statements are based on
management's current expectations, and actual results and future
events may differ materially due to risks and uncertainties,
including risks related to Amyris' liquidity and ability to fund
operating and capital expenses, risks related to potential delays
or failures in development, production and commercialization of
products, risks related to Amyris' reliance on third parties, and
other risks detailed from time to time in filings Amyris makes with
the Securities and Exchange Commission, including Annual Reports on
Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on
Form 8-K. Amyris disclaims any obligation to update information
contained in these forward-looking statements, whether as a result
of new information, future events, or otherwise.
Amyris, the Amyris logo, No Compromise, Biossance, Pipette, and
Purecane are trademarks or registered trademarks of Amyris, Inc. in
the U.S. and/or other countries.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/amyris-delivering-sustainable-alternative-to-shark-squalene-adjuvant--enabling-vaccines-for-all-with-no-sharks-killed-301143581.html
SOURCE Amyris, Inc.